Skip to main content
. Author manuscript; available in PMC: 2009 Feb 5.
Published in final edited form as: Diabetes Obes Metab. 2009 Feb;11(Suppl 1):74–83. doi: 10.1111/j.1463-1326.2008.01006.x

Fig. 2.

Fig. 2

(A) Transmitted paternal and maternal allele frequencies for type 1 diabetes (T1D) susceptibility alleles from analyses of parent-of-origin (POO) effects in T1D families; (B) non-transmitted paternal and maternal allele frequencies for T1D susceptibility alleles from analyses of non-inherited maternal HLA (NIMA) effects in T1D families. *The overall sample (n = 1780) compares maternal vs. paternal non-transmitted alleles using one affected child per family. †The male sample (n = 1376) compares maternal vs. paternal non-transmitted alleles using one affected male offspring per family. ‡The female sample (n = 1291) compares maternal vs. paternal non-transmitted alleles using one affected female offspring per family. HLA, human leucocyte antigen.